fig9
Figure 9. Schematic of PAG/Ce6 LPs for synergistic cancer therapy. (A) Preparation of PAG/Ce6 LPs and its action mechanism; (B) In vivo pharmacodynamics evaluation of PAG/Ce6 LPs, **P < 0.01, ***P < 0.001. Reproduced from Ref.[92] with permission from © 2024 Elsevier B.V.
